Management ChangeJul 7, 2026, 04:13 PM
CalciMedica Appoints Evgeny Zaytsev to Board; Fred Middleton to Retire
AI Summary
CalciMedica, Inc. announced changes to its Board of Directors. The Board increased its size from seven to eight directors and appointed Evgeny Zaytsev, M.D., Ph.D., as a Class I director, effective July 2, 2026. Dr. Zaytsev will receive an annual cash retainer of $40,000 and an option to purchase 20,000 shares of common stock. Concurrently, Fred Middleton informed the Board of his retirement, effective at the 2026 annual meeting of stockholders, after which the Board size will revert to seven directors.
Key Highlights
- Board size increased from seven to eight directors.
- Evgeny Zaytsev, M.D., Ph.D., appointed as a Class I director, effective immediately.
- Dr. Zaytsev's term expires at the 2027 annual meeting of stockholders.
- Dr. Zaytsev will receive an annual cash retainer of $40,000.
- Dr. Zaytsev was granted an option to purchase 20,000 shares of common stock.
- Fred Middleton informed the Board of his intention to retire at the 2026 annual meeting.
- Upon Mr. Middleton's retirement, the Board size will decrease to seven directors.
Price Impact
More from CALC